Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
pii: S0041-0101(12)00827-6. doi: 10.1016/j.toxicon.2012.12.004. [Epub ahead of print]
Abstract
This paper has been withdrawn.
pii: S0041-0101(12)00827-6. doi: 10.1016/j.toxicon.2012.12.004. [Epub ahead of print]